Asianet Newsable on MSN
Why is ALVO stock rising pre-market today?
The company reported that the study showed AVT80, its biosimilar candidate to Entyvio, met all primary endpoints.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results